Cited by 5,652Metabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Role of AMP-activated protein kinase in mechanism of metformin action

Open access

Zhou, Gaochao, Myers, Robert, Li, Ying, Chen, Yuli, Shen, Xiaolan, Fenyk-Melody, Judy, Wu, Margaret, Ventre, John, Doebber, Thomas, Fujii, Nobuharu, Musi, Nicolas, Hirshman, Michael F., Goodyear, Laurie J., Moller, David E.·2001·Journal of Clinical Investigation

DOI 10.1172/jci13505PMC PMC209533

Open this paper in CoChat — free account Open PDF

Abstract

Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action. Its glucose-lowering effect results from decreased hepatic glucose production and increased glucose utilization. Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver. AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metabolism. Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed. Activation of AMPK by metformin or an adenosine analogue suppresses expression of SREBP-1, a key lipogenic transcription factor. In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced. Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose production by hepatocytes. In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation. Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci13505

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 1×
“Malonyl-CoA is an initial substrate for de novo fatty acid biosynthesis, and it serves as a potent inhibitor of carnitine palmitoyl transferase I (CPT-I), a rate-limiting step for fatty acid oxidation (34).”
Background
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · cited 2×
“It is believed that metformin-mediated inhibition of hepatic glucose production (HGP) plays a major role in its glucose-lowering efficacy (2, 3, 6).”
Background
AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,048
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
Decreased IRS-2 and Increased SREBP-1c Lead to Mixed Insulin Resistance and Sensitivity in Livers of Lipodystrophic and ob/ob Mice
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport
Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W., & Goodyear, L. J. (1998) · Diabetes · doi:10.2337/diab.47.8.1369 · Cited by 774
Self-citation

Show all 36 references

Research works printed but not linked: 11

Schafer, 1983, Diabete Metab, 9, 148
10.1210/en.131.3.1165 · DOI
Winder, 1999, Am J Physiol, 277, E1
Merrill, 1997, Am J Physiol, 273, E1107
Goodyear, 2000, Exerc Sport Sci Rev, 28, 113
Cusi, 1998, Diabetes Reviews, 6, 89
Wiernsperger, 1999, Diabetes Metab, 25, 110
Hermann, 1979, Diabete Metab, 5, 233
Sterne, 1979, Research Clinical Forums, 1, 13
10.1042/0264-6021:3480607 · DOI · Paper page
10.1016/S1097-2765(00)00009-5 · DOI

Sorted by citations

Items 601–700 of 1,066

Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
Sun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y.-F. (2011) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-Kinase
Singh, D. K., Li, L., & Porter, T. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107144 · Cited by 183
Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5′ Adenosine Monophosphate–Activated Protein Kinase–Peroxisome Proliferator–Activated Receptor δ Pathway
Cheang, W. S., Tian, X. Y., Wong, W. T., Lau, C. W., Lee, S. S. T., Chen, Z., Yao, X., Wang, N., & Huang, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301938 · Cited by 180
Mechanism of Metformin: A Tale of Two Sites
Song, R. (2016) · Diabetes Care · doi:10.2337/dci15-0013 · Cited by 184
Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7
Fang, J., Yang, J., Wu, X., Zhang, G., Li, T., Wang, X., Zhang, H., Wang, C., Liu, G., & Wang, L. (2018) · Aging Cell · doi:10.1111/acel.12765 · Cited by 179
Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate
Scott, J. W., Norman, D., Hawley, S. A., Kontogiannis, L., & Hardie, D. G. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5316 · Cited by 179
Mechanisms and cell signaling in alcoholic liver disease
Beier, J. I., & McClain, C. J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.137 · Cited by 179
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic β-Cells
Gleason, C. E., Lu, D., Witters, L. A., Newgard, C. B., & Birnbaum, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610631200 · Cited by 182
5-Aminoimidazole-4-Carboxamide-1-β- d -Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase–Independent Effect on Glucokinase Translocation
Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N. F., Vertommen, D., Andréelli, F., Viollet, B., & Hue, L. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1178 · Cited by 183
Obesity and cancer: mechanistic insights from transdisciplinary studies
Allott, E. H., & Hursting, S. D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0400 · Cited by 187
Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications
Joshi, T., Singh, A. K., Haratipour, P., Sah, A. N., Pandey, A. K., Naseri, R., Juyal, V., & Farzaei, M. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28528 · Cited by 180
Nutrient–secretion coupling in the pancreatic islet β-cell: recent advances
Rutter, G. A. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(01)00013-9 · Cited by 180
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
Agius, L., Ford, B. E., & Chachra, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093240 · Cited by 183
Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Uchiyama, T., Suzuki, K., Nozaki, Y., Yoneda, K., Fujita, K., Yoneda, M., et al. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20637 · Cited by 181
Metabolic alterations and targeted therapies in prostate cancer
Flavin, R., Zadra, G., & Loda, M. F. (2010) · The Journal of Pathology · doi:10.1002/path.2809 · Cited by 178
Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways
Park, K., Min, A.-K., Koh, E. H., Kim, H. S., Kim, M., Park, H., Kim, Y.-D., Yoon, T.-S., Jang, B. K., Hwang, J. S., et al. (2008) · Hepatology · doi:10.1002/hep.22496 · Cited by 179
AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer
Hardie, D. G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390001 · Cited by 180
Effect of Metformin on Survival Outcomes in Diabetic Patients With Triple Receptor-Negative Breast Cancer
Bayraktar, S., Hernadez‐Aya, L. F., Lei, X., Meric‐Bernstam, F., Litton, J. K., Hsu, L., Hortobagyi, G. N., & Gonzalez‐Angulo, A. M. (2012) · Cancer · doi:10.1002/cncr.26439 · Cited by 176
Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus—systematic review and meta‐analysis
Hausenblas, H. A., Schoulda, J. A., & Smoliga, J. M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400173 · Cited by 176
Regulation of Glucose Transporter 3 Surface Expression by the AMP-Activated Protein Kinase Mediates Tolerance to Glutamate Excitation in Neurons
Weisová, P., Concannon, C. G., Devocelle, M., Prehn, J. H. M., & Ward, M. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0354-09.2009 · Cited by 161
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1224-1 · Cited by 178
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Lanning, N. J., Castle, J. P., Singh, S. J., Leon, A. N., Tovar, E. A., Sanghera, A., MacKeigan, J. P., Filipp, F. V., & Graveel, C. R. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0168-x · Cited by 175
Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction
Schaffer, B. E., Levin, R. S., Hertz, N. T., Maures, T. J., Schoof, M. L., Hollstein, P. E., Benayoun, B. A., Banko, M. R., Shaw, R. J., Shokat, K. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.009 · Cited by 184
Translation suppression promotes stress granule formation and cell survival in response to cold shock
Hofmann, S., Cherkasova, V., Bankhead, P., Bukau, B., & Stoecklin, G. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-04-0296 · Cited by 175
AMP-activated protein kinase promotes human prostate cancer cell growth and survival
Park, H. U., Suy, S., Danner, M. T., Dailey, V. K., Zhang, Y., Li, H., Hyduke, D. R., Collins, B. T., Gagnon, G. A., Kallakury, B., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0631 · Cited by 179
Review on rosmarinic acid extraction, fractionation and its anti-diabetic potential
Ngo, Y. L., Lau, C. H., & Chua, L. S. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.064 · Cited by 180
Metformin-Induced Glucagon-Like Peptide-1 Secretion Contributes to the Actions of Metformin in Type 2 Diabetes
Bahne, E., Sun, E. W. L., Young, R. L., Hansen, M., Sonne, D. P., Hansen, J. S., Rohde, U., Liou, A. P., Jackson, M. L., de Fontgalland, D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.93936 · Cited by 173
Thyrotropin Suppression by Metformin
Vigersky, R. A., Filmore-Nassar, A., & Glass, A. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1210 · Cited by 174
Effects of diabetes drugs on the skeleton
Meier, C., Schwartz, A. V., Egger, A., & Lecka‐Czernik, B. (2015) · Bone · doi:10.1016/j.bone.2015.04.026 · Cited by 174
Histological evaluation of AMPK signalling in primary breast cancer
Hadad, S. M., Baker, L., Quinlan, P., Robertson, K. E., Bray, S. E., Thomson, G., Kellock, D., Jordan, L. B., Purdie, C. A., Hardie, D. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-307 · Cited by 177
Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin
Tertti, K., Ekblad, U., Koskinen, P. J., Vahlberg, T. J., & Rönnemaa, T. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12017 · Cited by 173
Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
Katila, N., Bhurtel, S., Shadfar, S., Srivastav, S., Neupane, S., Ojha, U., Jeong, G.-S., & Choi, D.-Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.015 · Cited by 169
Activation of Protein Kinase Cζ by Peroxynitrite Regulates LKB1-dependent AMP-activated Protein Kinase in Cultured Endothelial Cells
Xie, Z., Dong, Y., Zhang, M., Cui, M.-Z., Cohen, R. A., Riek, U., Neumann, D., Schlattner, U., & Zou, M.-H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511178200 · Cited by 172
AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity
Luo, T., Nocon, A., Fry, J., Sherban, A., Rui, X., Jiang, B., Xu, X. J., Han, J., Yan, Y., Yang, Q., et al. (2016) · Diabetes · doi:10.2337/db15-1122 · Cited by 172
Effects of Metformin in Experimental Stroke
Li, J., Benashski, S. E., Venna, V. R., & McCullough, L. D. (2010) · Stroke · doi:10.1161/strokeaha.110.589697 · Cited by 172
AMPKα1 regulates the antioxidant status of vascular endothelial cells
Colombo, S. L., & Moncada, S. (2009) · Biochemical Journal · doi:10.1042/bj20090613 · Cited by 175
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Goldfine, A. B., & Shoelson, S. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88884 · Cited by 176
Intramyocellular lipids and insulin resistance
Machann, J., Häring, H. U., Schick, F., & Stümvoll, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00339.x · Cited by 177
Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective
Gusdon, A. M., Song, K., & Qu, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/637027 · Cited by 172
AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart
Sambandam, N., & Lopaschuk, G. D. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00065-6 · Cited by 177
Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion
Leclerc, I., Woltersdorf, W. W. W., Xavier, G. D. S., Rowe, R. L., Cross, S. E., Korbutt, G. S., Rajotte, R. V., Smith, R. M., & Rutter, G. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00532.2003 · Cited by 173
Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin
Takiyama, Y., Harumi, T., Watanabe, J., Fujita, Y., Honjo, J., Shimizu, N., Makino, Y., & Haneda, M. (2011) · Diabetes · doi:10.2337/db10-0655 · Cited by 170
Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival
Liu, X., Peyton, K. J., Shebib, A. R., Wang, H., Korthuis, R. J., & Durante, W. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00749.2010 · Cited by 170
AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome
Christ‐Crain, M., Kola, B., Lolli, F., Fekete, C., Seboek, D., Wittmann, G., Feltrin, D., Igreja, S., Ajodha, S. J., Harvey-White, J. D., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-094144 · Cited by 175
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
Phoenix, K. N., Vumbaca, F., & Claffey, K. P. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9916-5 · Cited by 173
Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*
Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 173
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Afzal, M. Z., Mercado, R. R., & Shirai, K. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0375-1 · Cited by 173
Lafora disease — from pathogenesis to treatment strategies
Nitschké, F., Ahonen, S., Nitschke, S., Mitra, S., & Minassian, B. A. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0057-0 · Cited by 174
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
Silva, N. M. L. E., Lam, M. P., Soares, C. N., Munoz, D. P., Milev, R. V., & Felice, F. G. D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00057 · Cited by 178
High-Efficiency Induction of Neural Conversion in Human ESCs and Human Induced Pluripotent Stem Cells with a Single Chemical Inhibitor of Transforming Growth Factor Beta Superfamily Receptors
Zhou, J., Su, P., Li, D., Tsang, S., Duan, E., & Wang, F. (2010) · Stem Cells · doi:10.1002/stem.504 · Cited by 168
Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus
Wheeler, G. N., & Brändli, A. W. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21967 · Cited by 185
Caloric restriction: From soup to nuts
Spindler, S. R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.10.003 · Cited by 169
Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons
Ullah, I., Ullah, N., Naseer, M. I., Lee, H., & Kim, M. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-11 · Cited by 170
Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α
Terkeltaub, R. A., Yang, B., Lotz, M., & Liu‐Bryan, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30333 · Cited by 168
mTOR signaling in tumorigenesis
Xu, K. L., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 167
Regulation of eNOS Enzyme Activity by Posttranslational Modification
Heiß, E. H., & Dirsch, V. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660745 · Cited by 171
Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase
Pilon, G., Dallaire, P., & Marette, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401390200 · Cited by 175
Reduction of lipid accumulation in HepG2 Cells by luteolin is associated with activation of AMPK and Mitigation of oxidative stress
Liu, J., Ma, Y., Wang, Y., Du, Z., Shen, J., & Peng, H. (2010) · Phytotherapy Research · doi:10.1002/ptr.3305 · Cited by 168
Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice
Geerling, J. J., Boon, M. R., van der Zon, G. C., van den Berg, S. A. A., van den Hoek, A. M., Lombès, M., Princen, H. M. G., Havekes, L. M., Rensen, P. C. N., & Guigas, B. (2013) · Diabetes · doi:10.2337/db13-0194 · Cited by 173
Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat
Narasimhan, A., Mayilvanan, C., & Karundevi, B. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0002 · Cited by 166
AMP-activated protein kinase: a key system mediating metabolic responses to exercise
HARDIE, D. G. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000106171.38299.64 · Cited by 165
Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders
Viollet, B., Mounier, R., Leclerc, J., Yazigi, A., Foretz, M., & Andréelli, F. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.10.004 · Cited by 168
AMP-Activated Protein Kinase and Autophagy
Meijer, A. J., & Codogno, P. (2007) · Autophagy · doi:10.4161/auto.3710 · Cited by 165
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase
Wang, Y., Huang, Y., Lam, K. S. L., Li, Y., Wong, W. T., Ye, H., Lau, C., Vanhoutte, P. M., & Xu, A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp078 · Cited by 167
Self-citation
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Drzewoski, J., & Hanefeld, M. (2021) · Pharmaceuticals · doi:10.3390/ph14020122 · Cited by 173
Rosiglitazone but Not Metformin Enhances Insulin- and Exercise-Stimulated Skeletal Muscle Glucose Uptake in Patients With Newly Diagnosed Type 2 Diabetes
Hällsten, K., Virtanen, K. A., Lönnqvist, F., Sipilä, H. T., Oksanen, A., Viljanen, T., Rönnemaa, T., Viikari, J. S. A., Knuuti, J. M., & Nuutila, P. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3479 · Cited by 165
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Wong, A., Howie, J., Petrie, J. R., & Lang, C. C. (2009) · Clinical Science · doi:10.1042/cs20080066 · Cited by 170
Microarray profiling of gene expression in human adipocytes in response to anthocyanins
Tsuda, T., Ueno, Y., Yoshikawa, T., Kojo, H., & Osawa, T. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.042 · Cited by 165
AMP-Activated Protein Kinase: A Key Stress Signaling Pathway in the Heart
Young, L. H., Li, J., Baron, S. J., & Russell, R. R. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.04.005 · Cited by 165
Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK
Avivar‐Valderas, A., Bobrovnikova-Marjon, E. V., Diehl, J. A., Bardeesy, N. M., Debnath, J., & Aguirre‐Ghiso, J. A. (2012) · Oncogene · doi:10.1038/onc.2012.512 · Cited by 163
Contraindications can damage your health—is metformin a case in point?
Holstein, A., & Stümvoll, M. (2005) · Diabetologia · doi:10.1007/s00125-005-0026-1 · Cited by 163
Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes
Xie, Z., Zhang, J., Wu, J., Viollet, B., & Zou, M. (2008) · Diabetes · doi:10.2337/db08-0610 · Cited by 165
Retracted
Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus
Zang, L., Shimada, Y., & Nishimura, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-01432-w · Cited by 171
AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase
Kefas, B. A., Cai, Y., Ling, Z., Heimberg, H., Hue, L., PIPELEERS, D. G., & de Casteele, M. V. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300151 · Cited by 163
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Patel, K., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P. M., Peggie, M. W., Deák, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5535 · Cited by 171
Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
Gronich, N., & Rennert, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.169 · Cited by 167
Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction
Karnewar, S., Neeli, P. K., Panuganti, D., Kotagiri, S., Mallappa, S., Jain, N., Jerald, M. K., & Kotamraju, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.018 · Cited by 161
New mechanisms of metformin action: Focusing on mitochondria and the gut
Hur, K. Y., & Lee, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12328 · Cited by 161
5′-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle
Frøsig, C., Jørgensen, S. B., Hardie, D. G., Richter, E. A., & Wojtaszewski, J. F. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00317.2003 · Cited by 161
Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
Tan, B., Yao, W., Ge, J., Peng, X., Du, X., Zhang, R., Yao, B., Xie, K., Li, L., Dong, H., et al. (2011) · Cancer · doi:10.1002/cncr.26151 · Cited by 161
An energetic tale of AMPK-independent effects of metformin
Miller, R., & Birnbaum, M. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43661 · Cited by 167
Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
Saito, S., Furuno, A., Sakurai, J., Sakamoto, A., Park, H.-R., Shin‐ya, K., Tsuruo, T., & Tomida, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2689 · Cited by 164
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Sonnenblick, A., Agbor‐Tarh, D., Bradbury, I., Cosimo, S. D., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J. R., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7722 · Cited by 161
Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate–activated protein kinase in human HepG2 cells and obese mice
Hwang, Y. P., Choi, J. H., Han, E. H., Kim, H. G., Wee, J., Jung, K. O., Jung, K. H., Kwon, K., Jeong, T. C., Chung, Y., et al. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.09.026 · Cited by 160
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
Ford, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M. E., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 164
Metformin revisited: re‐evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents
Goodarzi, M. O., & Bryer‐Ash, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00448.x · Cited by 163
Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53
Lee, C., Inoki, K., Karbowniczek, M., Petroulakis, E., Sonenberg, N., Henske, E. P., & Guan, K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601900 · Cited by 160
Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?
Hardie, D. G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3300 · Cited by 166
Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program
Mather, K. J., Funahashi, T., Matsuzawa, Y., Edelstein, S. L., Bray, G. A., Kahn, S. E., Crandall, J. P., Marcovina, S. M., Goldstein, B., Goldberg, R. B., et al. (2008) · Diabetes · doi:10.2337/db07-1419 · Cited by 161
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
Ong, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
Koh, A., Mannerås-Holm, L., Yunn, N.-O., Nilsson, P. M., Ryu, S. H., Molinaro, A., Perkins, R., Smith, J. G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.012 · Cited by 165
Insulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159
Adenosine signaling contributes to ethanol-induced fatty liver in mice
Peng, Z., Borea, P. A., Wilder, T., Yee, H. T., Chiriboga, L. A., Blackburn, M. R., Azzena, G., Resta, G., & Cronstein, B. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37409 · Cited by 162
Prevalence, predisposition and prevention of type II diabetes
Cheng, D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-29 · Cited by 164
GLUT2 Accumulation in Enterocyte Apical and Intracellular Membranes
Ait-Omar, A., Monteiro-Sepulveda, M., Poitou, C., Gall, M. L., Cotillard, A., Gilet, J., Garbin, K., Houllier, A., Chateau, D., Lacombe, A., et al. (2011) · Diabetes · doi:10.2337/db10-1740 · Cited by 158
Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice
Laiglesia, L. M., Lorente‐Cebrián, S., Martínez‐Fernández, L., Sáinź, N., Prieto-Hontoria, P. L., Burrell, M. A., Rodríguez‐Ortigosa, C. M., Martínez, J. A., & Moreno-Aliaga, M. J. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.226 · Cited by 159
Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice
Lee, J., Hong, S.-W., Chae, S. W., Kim, D. H., Choi, J. H., Bae, J. C., Park, S. E., Rhee, E.-J., Park, C.-Y., Oh, K.-W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031394 · Cited by 157
Mitochondrial Dynamics and Mitochondrial Dysfunction in Diabetes.
Wada, J., & Nakatsuka, A. (2016) · PubMed · doi:10.18926/amo/54413 · Cited by 161
AMPK and NRF2: Interactive players in the same team for cellular homeostasis?
Petsouki, E., Cabrera, S. N. S., & Heiß, E. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.014 · Cited by 162

Authors: Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., & Moller, D. E.
Affiliations: Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Zhou, Gaochao
ORCID: Zhou, Gaochao
Li, Ying
Shen, Xiaolan
Musi, Nicolas
Hirshman, Michael F.
Goodyear, Laurie J.
Moller, David E.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2001-10-15
Volume: 108
Issue: 8
Pages: 1167-1174
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci13505
PMC: PMC209533
OpenAlex: W2138226825
Cited by: 5,652
References: 36
Citations by year: 2026: 149 · 2025: 182 · 2024: 198 · 2023: 234 · 2022: 270 · 2021: 312 · 2020: 272 · 2019: 310 · 2018: 306 · 2017: 304 · 2016: 296 · 2015: 331 · 2014: 307 · 2013: 295 · 2012: 291
FWCI: 26.36
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords: metformin, AMPK, type 2 diabetes, hepatic glucose production, acetyl-CoA carboxylase, SREBP1, lipogenesis, fatty acid oxidation, glucose uptake, skeletal muscle, hepatic lipid metabolism, AMPK inhibitors
MeSH terms: Aminoimidazole Carboxamide, Animals, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Enzyme Activation, Fatty Acids, Glucose, Humans, Hypoglycemic Agents, Male, Metformin, Multienzyme Complexes, Protein Kinases, Pyrazoles, Pyrimidines, Ribonucleotides, RNA, Messenger, Transcription Factors, Gene Expression, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Muscle, Skeletal, CCAAT-Enhancer-Binding Proteins, Hepatocytes, Protein Kinase Inhibitors, Rats, Sterol Regulatory Element Binding Protein 1, AMP-Activated Protein Kinases, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of AMP-activated protein kinase in mechanism of metformin action

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks